表紙
市場調查報告書
商品編碼
1003039

視神經脊髓炎:全球臨床實驗趨勢 2021年前半期

Neuromyelitis Optica (Devic's Syndrome) - Global Clinical Trials Review, H2, 2021

出版日期: | 出版商: GlobalData | 英文 103 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供視神經脊髓炎臨床實驗相關的基本資料數據,彙整先進7個國家(G7)及新興7個國家實施(E7)的實驗數量及受驗者的募集情況,各階段趨勢,進行臨床實驗的主要製藥企業及研究機關簡介等資料。

目錄

  • 報告指南
  • 調查範圍
  • 各國臨床實驗數量
  • 實驗數量和平均實驗人數
  • 亞太地區主要5國臨床實驗數量
  • 歐洲主要5國臨床實驗數量
  • 北美主要國家臨床實驗數量
  • 中東·非洲主要國家臨床實驗數量
  • 中南美主要國家臨床實驗數量
  • G7各國臨床實驗數量:中樞神經系統臨床實驗上視神經脊髓炎的比例
  • G7各國臨床實驗數量:各階段
  • G7各國臨床實驗數量:各臨床實驗狀況
  • E7各國臨床實驗數量:中樞神經系統臨床實驗上視神經脊髓炎的比例
  • E7各國臨床實驗數量:各階段
  • E7各國臨床實驗數量:各臨床實驗狀況
  • 臨床實驗數量:各階段
  • 進行中的實驗數量:各階段
  • 臨床實驗數量:各臨床實驗狀況
  • 臨床實驗數量:各端點狀況
  • 一定期間募集的受驗人數
  • 臨床實驗數量:各贊助商類型
  • 主要贊助商
  • 參加視神經脊髓炎治療藥臨床實驗的前幾名企業
  • 有前途的藥品
  • 臨床實驗的簡介

附錄

  • 簡稱
  • 定義
  • 調查手法
  • 2次調查
  • 關於GlobalData
  • 諮詢方式
  • 贊助商
目錄
Product Code: GDHC6787CTIDB

GlobalData's clinical trial report, "Neuromyelitis Optica (Devic's Syndrome) - Global Clinical Trials Review, H2, 2021" provides an overview of Neuromyelitis Optica (Devic's Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Neuromyelitis Optica (Devic's Syndrome) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

List of Tables

  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Region, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, North America, Top Countries, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2021*
  • Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, G7 Countries (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, E7 Countries (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Phase, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*

List of Figures

List of Figures

  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Region (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, North America, Top Countries (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2021*
  • Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, G7 Countries (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2021*
  • Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, E7 Countries (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Phase (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, by End Point Status, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2016-2020
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2021*
  • Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2021*
  • GlobalData Methodology